RenovoRx
RNXT
13 hedge funds and large institutions have $2.49M invested in RenovoRx in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
18% more funds holding
Funds holding: 11 → 13 (+2)
6% more capital invested
Capital invested by funds: $2.35M → $2.49M (+$134K)
0.46% more ownership
Funds ownership: 13.1% → 13.56% (+0.46%)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$74.5K |
| 2 |
CG
Colony Group
Boston,
Massachusetts
|
+$34.2K |
| 3 |
ACA
Affinity Capital Advisors
Berkeley,
California
|
+$24.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.94K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$52 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$32.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$10.8K |
| 3 |
Morgan Stanley
New York
|
-$2.61K |
RNXT Hedge Fund Activity: Q3 2022 in Review
13 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q3 2022, worth a combined $2.49M — up 5.7% from $2.35M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RNXT positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $74.5K. The largest seller was Bank of America, cutting an estimated $32.2K.
- 13 institutional investors held RenovoRx (RNXT) as of Q3 2022, up from 11 in Q2 2022.
- Funds reported $2.49M of RenovoRx stock for Q3 2022, up 5.7% quarter-over-quarter.
- 3 funds opened new RenovoRx positions in Q3 2022 and 1 closed out, a net change of +2 holders.
- The largest RenovoRx buyer in Q3 2022 was Geode Capital Management, an estimated $74.5K added.
- The largest RenovoRx seller in Q3 2022 was Bank of America, an estimated $32.2K sold.
Based on aggregated 13F filings for Q3 2022.